For the quarter ended September 2025, Journey Medical Corporation (DERM) reported revenue of $17.63 million, up 20.5% over the same period last year. EPS came in at -$0.09, compared to -$0.12 in the year-ago quarter.The reported revenue represents a surprise of -0.39% over the Zacks Consensus Estimate of $17.7 million. With the consensus EPS estimate being -$0.08, the EPS surprise was -12.5%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectat ...